Patent ID: 11918582
Assignee: RAPT THERAPEUTICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 5:
6. The compound of claim 1, or a pharmaceutically acceptable salt thereof, wherein R5 is:, , wherein:
W is —C(O), —S(O), —S(O)2 or —S(NH)(O);
R6 is a substituted or unsubstituted alkyl, —OCH3 or —NR14R15;
R7 is H or —CH3;
R8, R9, R10 and R11 are each independently H, substituted or unsubstituted alkyl, —OH or halogen;
R12 and R13 are each independently H or substituted or unsubstituted alkyl, or R8 and R9, R9 and R10, R10 and R11, R11 and R12, and R12 and R13 may optionally be joined to form a substituted or unsubstituted cycloalkyl;
R14 and R15 are each independently H or substituted or unsubstituted alkyl;
R16 is —OH, a substituted or unsubstituted alkyl, —COOH, —OCH3, —NHC(O)CH3, —NHC(O)CH2OH, —NHSO2CH3 or —C(O)NR17R17;
R17 and R18 are each independently H or a substituted or unsubstituted alkyl; and
q is 0, 1 or 2.